|

TmPSMA-02 CAR T Cells Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1: 1

Top Sponsors

  • University of Pennsylvania1

Indications

  • Metastatic Castrate Resistant Prostate Cancer (mCRPC)1
  • Cancer1

Philadelphia, Pennsylvania1 trial

TmPSMA-02 in mCRPC

Abramson Cancer Center of the University of Pennsylvania

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.